Prevalence of Candida dubliniensis Fungemia in Argentina: Identification by a Novel Multiplex PCR and Comparison of Different Phenotypic Methods

Mycopathologia

Volumn 172, Issue 5, 2011, Pages 407-414

  Bosco Borgeat, Maria Eugenia ^a   Taverna, Constanza Giselle ^a   Cordoba, Susana ^a   Isla, Maria Guillermina ^a   Murisengo, Omar Alejandro ^a   Szusz, Wanda ^a   Vivot, Walter ^a   Davel, Graciela ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

Author keywords

Candida albicans; Candida dubliniensis; Fungemia; Identification; Susceptibility

Indexed keywords

ANTIFUNGAL AGENT; FUNGAL DNA; FUNGAL PROTEIN; MEMBRANE PROTEIN; PHR1 PROTEIN, CANDIDA ALBICANS; PYRROLE DERIVATIVE;

ADOLESCENT; ADULT; ANTIFUNGAL RESISTANCE; ARGENTINA; ARTICLE; CANDIDA; CANDIDEMIA; CLASSIFICATION; COMPARATIVE STUDY; DNA SEQUENCE; DRUG EFFECT; FEMALE; FUNGUS SPORE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; PHENOTYPE;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; ARGENTINA; AZOLES; BASE SEQUENCE; CANDIDA; CANDIDEMIA; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; FEMALE; FUNGAL PROTEINS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOLOGICAL TYPING TECHNIQUES; PHENOTYPE; SEQUENCE ANALYSIS, DNA; SPORES, FUNGAL;

CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; HELIANTHUS; NICOTIANA TABACUM;

EID: 80053942309     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9450-6     Document Type: Article

References (33)

1. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002; 50(4): 243-60. doi: 10. 1053/jhin. 2001. 1151.
2. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology. 1995; 141(Pt 7): 1507-21.
3. Brandt ME, Harrison LH, Pass M, Sofair AN, Huie S, Li RK, et al. Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis. 2000; 6(1): 46-9.
4. Jabra-Rizk MA, Johnson JK, Forrest G, Mankes K, Meiller TF, Venezia RA, et al. Prevalence of Candida dubliniensis fungemia at a large teaching hospital. Clin Infect Dis. 2005; 6(1): 1064-7. doi: 10. 1086/432943.
5. Sancak B, Rex JH, Paetznick V, Chen E, Rodriguez J. Evaluation of a method for identification of Candida dubliniensis bloodstream isolates. J Clin Microbiol. 2003; 41(1): 489-91.
6. Sullivan DJ, Moran GP, Pinjon E, Al-Mosaid A, Stokes C, Vaughan C, et al. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res. 2004; 4(4-5): 369-76. doi: S156713560300240X[pii].
7. van Hal SJ, Stark D, Harkness J, Marriott D. Candida dubliniensis meningitis as delayed sequela of treated C. dubliniensis fungemia. Emerg Infect Dis. 2008; 14(2): 327-9.
8. McManus BA, Coleman DC, Moran G, Pinjon E, Diogo D, Bougnoux ME, et al. Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans. J Clin Microbiol. 2008; 46((2): 652-64. doi: 10. 1128/JCM. 01574-07.
9. Gee SF, Joly S, Soll DR, Meis JF, Verweij PE, Polacheck I, et al. Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo. J Clin Microbiol. 2002; 40(2): 556-74.
10. Sullivan D, Coleman D. Candida dubliniensis: characteristics and identification. J Clin Microbiol. 1998; 36(2): 329-34.
11. Gales AC, Pfaller MA, Houston AK, Joly S, Sullivan DJ, Coleman DC, et al. Identification of Candida dubliniensis based on temperature and utilization of xylose and alpha-methyl-d-glucoside as determined with the API 20C AUX and vitek YBC systems. J Clin Microbiol. 1999; 37(12): 3804-8.
12. Khan ZU, Ahmad S, Mokaddas E, Chandy R. Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol. 2004; 42(10): 4796-8. doi: 10. 1128/JCM. 42. 10. 4796-4798. 2004.
13. Alves SH, Milan EP, de Laet Sant'Ana P, Oliveira LO, Santurio JM, Colombo AL. Hypertonic sabouraud broth as a simple and powerful test for Candida dubliniensis screening. Diagn Microbiol Infect Dis. 2002; 43(1): 85-6. doi: S0732889302003681[pii].
14. Moran GP, Sullivan DJ, Henman MC, McCreary CE, Harrington BJ, Shanley DB, et al. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother. 1997; 41(3): 617-23.
15. Rodero L, Hochenfellner F, Córdoba S, Vivot W, Perrota D, Canteros C et al. editors. Candida dubliniensis asociada a candidiasis orofaríngea en pacientes HIV. VIII Congreso y XVIII Jornadas Argentinas de Micología; 1998 12 al 14 de agosto; San Miguel de Tucumán, Tucumán, Argentina.
16. Rodero L, Losso M, Canteros C, Hochenfellner F, Davel G. Candida dubliniensis: 1st isolation in Argentina. Rev Argent Microbiol. 1998; 30(1): 39-41.
17. Romeo O, Racco C, Criseo G. Amplification of the hyphal wall protein 1 gene to distinguish Candida albicans from Candida dubliniensis. J Clin Microbiol. 2006; 44(7): 2590-2. doi: 10. 1128/JCM. 00125-06.
18. Gumral R, Sancak B, Guzel AB, Saracli MA, Ilkit M. Lack of Candida africana and Candida dubliniensis in vaginal candida albicans isolates in Turkey using HWP1 gene polymorphisms. Mycopathologia. 2011. doi: 10. 1007/s11046-011-9401-2.
19. Iwen PC, Hinrichs SH, Rupp ME. Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. Med Mycol. 2002; 40(1): 87-109.
20. Donnelly SM, Sullivan DJ, Shanley DB, Coleman DC. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology. 1999; 145(Pt 8): 1871-82.
21. Kurzai O, Heinz WJ, Sullivan DJ, Coleman DC, Frosch M, Muhlschlegel FA. Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J Clin Microbiol. 1999; 37(5): 1587-90.
22. Al Mosaid A, Sullivan DJ, Coleman DC. Differentiation of Candida dubliniensis from Candida albicans on Pal's agar. J Clin Microbiol. 2003; 41(10): 4787-9.
23. Kurtzman CP, Fell JW. The yeast: a taxonomic study. 4th ed. Elsevier; 1998.
24. EUCAST. Definitive document EDef 7. 1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect. 2008; 14(4): 398-405. doi: 10. 1111/j. 1469-0691. 2007. 01935. x.
25. EUCAST. Technical note on fluconazole. Clin Microbiol Infect. 2008; 14(2): 193-5. doi: 10. 1111/j. 1469-0691. 2007. 01899. x.
26. EUCAST. Technical note on voriconazole. Clin Microbiol Infect. 2008; 14(10): 985-7. doi: 10. 1111/j. 1469-0691. 2008. 02087. x.
27. Reference method for broth dilution antifungal susceptibility testing of yeast; approved standard. 3rd ed. CLSI document M27-A3. Wayne, Pennsylvania 19087-1898, USA: Clinical and Laboratory Standards Institute (CLSI). 2008.
28. Reference method for broth dilution antifungal susceptibility testing of Yeast; Third Informational Supplement. CLSI document M27-S3. Wayne, Pennsylvania 19087-1898 USA: Clinical and Laboratory Standards Institute (CLSI); 2008.
29. Fernandez A, Jewtuchowicz VM, Malzone MC, Lopez-Daneri G, Saa G, Iovannitti CA, et al. Phenotypic and genotypic characterisation of Candida dubliniensis isolate in a patient with disseminated candidiasis. Mycoses.
30. Binolfi A, Biasoli MS, Luque AG, Tosello ME, Magaro HM. High prevalence of oral colonization by Candida dubliniensis in HIV-positive patients in Argentina. Med Mycol. 2005; 43(5): 431-7.
31. Jewtuchowicz VM, Mujica MT, Brusca MI, Sordelli N, Malzone MC, Pola SJ, et al. Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina. Oral Microbiol Immunol. 2008; 23(6): 505-9. doi: 10. 1111/j. 1399-302X. 2008. 00465. x.
32. Pineda G, Scollo K, Santiso G, Lehmann E, Arechavala A. Isolation of Candida dubliniensis in different clinical samples. Analysis of phenotypical methods to differentiate it from Candida albicans. Rev Argent Microbiol. 2008; 40(4): 211-7.
33. Salkin IF, Pruitt WR, Padhye AA, Sullivan D, Coleman D, Pincus DH. Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the US. J Clin Microbiol. 1998; 36(5): 1467.